// Press Release
Azooka Labs unveils Safe MTM to Store COVID-19 Samples at Room Temperature for up to a week
Azooka Labs unveils Safe MTM to Store COVID-19 Samples at Room Temperature for up to a week Molecular Transport Medium at the price of VTM BANGALORE, India – December 15th, 2020 Azooka Labs, a leading safe fluorophore company with specialization in Molecular Biology products, reveals its first range of novel COVID-19 diagnostics products. RNA Wrapr is a … Continue reading Azooka Labs unveils Safe MTM to Store COVID-19 Samples at Room Temperature for up to a week
New Study Gives Canada a “B” Grade for Overall Cancer Mortality
New Study Gives Canada a “B” Grade for Overall Cancer Mortality Improvements in screening, early detection, and treatment contribute to decreased risk of dying from cancer in Canada Canada’s mortality rate due to lung cancer is high compared to most peer countries Differences exist in overall cancer mortality rates among the provinces MISSISSAUGA, ON, Dec. 15, … Continue reading New Study Gives Canada a “B” Grade for Overall Cancer Mortality
Online Health Promotion Program Shown to Significantly Improve the Physical and Mental Health of Canadians During the Pandemic
Online Health Promotion Program Shown to Significantly Improve the Physical and Mental Health of Canadians During the Pandemic MONTREAL, Dec. 15, 2020 /CNW/ – During the Covid 19 pandemic, over 100 Canadians joined the MissionVAV Drop 5 Mission to: increase their daily physical activity, improve their healthy food choices, reduce their fatigue and stress levels, … Continue reading Online Health Promotion Program Shown to Significantly Improve the Physical and Mental Health of Canadians During the Pandemic
Health Canada Approves VENCLEXTA® (venetoclax) in combination with azacitidine or low dose cytarabine for untreated Acute Myeloid Leukemia (AML)
Health Canada Approves VENCLEXTA® (venetoclax) in combination with azacitidine or low dose cytarabine for untreated Acute Myeloid Leukemia (AML) Health Canada’s approval of VENCLEXTA for newly diagnosed AML patients who are ineligible for intensive chemotherapy is supported by data from two Phase 3 trials – VIALE-A (M15-656) and VIALE-C (M16-043)1. The VIALE-A trial demonstrated a … Continue reading Health Canada Approves VENCLEXTA® (venetoclax) in combination with azacitidine or low dose cytarabine for untreated Acute Myeloid Leukemia (AML)
CORDANT HEALTH SOLUTIONS AND SPERO HEALTH INCREASE NALOXONE ACCESS, SAVE LIVES
CORDANT HEALTH SOLUTIONS AND SPERO HEALTH INCREASE NALOXONE ACCESS, SAVE LIVES PIKEVILLE, Ky., Dec. 15, 2020 — Cordant Health Solutions®, a leader in providing innovative tools for patients in addiction treatment programs, and Spero Health, an integrated health services organization specializing in the treatment of patients with opioid use disorder, today announced promising results in a … Continue reading CORDANT HEALTH SOLUTIONS AND SPERO HEALTH INCREASE NALOXONE ACCESS, SAVE LIVES
Canadian Vaccine Catalogue releases critical standardized terminology for COVID-19 vaccines
Canadian Vaccine Catalogue releases critical standardized terminology for COVID-19 vaccines OTTAWA, ON, Dec. 15, 2020 /CNW/ – Standardized vaccine terminology and product information will be critical in the rollout of COVID-19 vaccines to ensure consistency across Canada. The Canadian Vaccine Catalogue (CVC) is the comprehensive, standards-based resource for vaccine terminology and vaccine product information in the country. CANImmunize, … Continue reading Canadian Vaccine Catalogue releases critical standardized terminology for COVID-19 vaccines
Switch Health Receives Health Canada Authorization for COVID-19 At-Home Collection Kits
Switch Health Receives Health Canada Authorization for COVID-19 At-Home Collection Kits Health Canada authorizes Switch Health’s COVID-19 at-home specimen collection kits. At-home specimen collection kits will soon be available online and in participating pharmacy retailers. Switch Health launches proprietary videoconferencing software, ASMO, for step-by-step instructional support for guided collection at-home. ASMO connects directly to partner … Continue reading Switch Health Receives Health Canada Authorization for COVID-19 At-Home Collection Kits
Ontario’s doctors’ plans for delivering COVID vaccine more urgent in face of record 2,275 daily cases
Ontario’s doctors’ plans for delivering COVID vaccine more urgent in face of record 2,275 daily cases TORONTO, Dec. 15, 2020 /CNW/ – Ontario’s doctors expressed concern that a record 2,275 Ontarians have tested positive for COVID-19 in one day and call on the government to ensure that initial limited supplies of the vaccine are given to … Continue reading Ontario’s doctors’ plans for delivering COVID vaccine more urgent in face of record 2,275 daily cases
CSACI Statement on potential adverse reactions to COVID-19 vaccines
CSACI Statement on potential adverse reactions to COVID-19 vaccines OTTAWA, ON, Dec. 15, 2020 /CNW/ – The Canadian Society of Allergy & Clinical Immunology (CSACI) is aware of media reports of two healthcare workers at the National Health Services in the United Kingdom (UK) who experienced adverse reactions on December 8, 2020 after receiving the Pfizer/BioNTech … Continue reading CSACI Statement on potential adverse reactions to COVID-19 vaccines
Loyalist College Ranks #1 For Industry Research Income as Percentage of Total Research Income
Loyalist College Ranks #1 For Industry Research Income as Percentage of Total Research Income BELLEVILLE, ON, Dec. 15, 2020 /CNW/ – Loyalist College reached an institutional milestone today when it was recognized as one of Canada’s top 50 research colleges. This is the first time Loyalist has ranked on Research Infosource Inc.’s annual list, placing first in … Continue reading Loyalist College Ranks #1 For Industry Research Income as Percentage of Total Research Income
